Suchergebnisse - "PCSK9i"

PubPharm (59)

1

PCSK9 inhibition and broad health outcomes : A Mendelian randomization phenome‑wide association study

enthalten in: Pharmacological research | 2024

von Zhang, K. | Bian, Q.

2

Effect of Empagliflozin with or without the Addition of Evolocumab on HDL Subspecies in Individuals with Type 2 Diabetes Mellitus : A Post Hoc Analysis of the EXCEED-BHS3 Trial

enthalten in: International journal of molecular sciences | 2024

von Bonilha, I. | Gomes, �. | Carmo, H. | +13

3

Psychiatric disorders associated with PCSK9 inhibitors : A real-world, pharmacovigilance study

enthalten in: CNS neuroscience & therapeutics | 2024

von Deng, Z. | Liu, J. | Gong, H. | +3

4

Evolocumab effectiveness in the real-world setting : Austrian data from the pan-European observational HEYMANS study

enthalten in: Wiener klinische Wochenschrift | 2024

von Ebenbichler, C. | Drexel, H. | Hanusch, U. | +6

5

Novel and Emerging LDL-C Lowering Strategies : A New Era of Dyslipidemia Management

enthalten in: Journal of clinical medicine | 2024

von Agnello, F. | Ingala, S. | Laterra, G. | +2

6

LDL-C Lowering in Prevention of Atherosclerotic Cardiovascular Disease : Another Step Forward in This Lifelong Marathon

enthalten in: Journal of the American College of Cardiology | 2024

von Nambi, V. | Abushamat, L.

7

The Effect of PCSK9 Inhibitors on LDL-C Target Achievement in Patients with Homozygous Familial Hypercholesterolemia : A Retrospective Cohort Analysis

enthalten in: Advances in therapy | 2024

von Alshahrani, A. | Kholaif, N. | Al-Khnifsawi, M. | +2

ErratumIn: Adv Ther. 2024 Mar 13;:. - PMID 38480664

8

Evolocumab use in clinical practice in Switzerland : final data of the observational HEYMANS cohort study

enthalten in: Therapeutic advances in cardiovascular disease | 2024

von Sudano, I. | Krähenbühl, S. | Mach, F. | +5

9

PCSK9 inhibitor protects against ischemic cerebral injury by attenuating inflammation via the GPNMB/CD44 pathway

enthalten in: International immunopharmacology | 2024

von Zheng, Y. | Zhu, T. | Li, G. | +2

10

The Effect of PCSK9 Inhibitors on LDL-C Target Achievement in Patients with Homozygous Familial Hypercholesterolemia: A Retrospective Cohort Analysis

enthalten in: Advances in therapy | 2024

von Alshahrani, A. | Kholaif, N. | Al-Khnifsawi, M. | +2

1
2
3
4
5
6
Nächster »
[6]